Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry

PURPOSE: There is a major clinical need to devise an optimal treatment sequence for the multiple therapy options available for patients with metastatic castration-resistant prostate cancer (mCRPC). In the absence of prospective clinical trials, sequencing information can be derived from large, real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaza, Hideyuki, Procopio, Giuseppe, Pripatnanont, Choosak, Facchini, Gaetano, Fava, Sergio, Wheatley, Duncan, Leung, Kwong Chuen, Butt, Mohammad, Silva, Alberto, Castillo, Liliana, Karavasilis, Vasilios, Ӧzatılgan, Ayse, Hitier, Simon, Ecstein-Fraisse, Evelyne B., Ӧzgüroḡlu, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223517/
https://www.ncbi.nlm.nih.gov/pubmed/30260754
http://dx.doi.org/10.1200/JGO.18.00009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223517/
https://www.ncbi.nlm.nih.gov/pubmed/30260754
http://dx.doi.org/10.1200/JGO.18.00009

Ejemplares similares